Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model
| Data(s) |
24/05/2014
|
|---|---|
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/63927/1/art%253A10.1007%252Fs00259-014-2798-3.pdf Grünberg, Jürgen; Lindenblatt, Dennis; Dorrer, Holger; Cohrs, Susan; Zhernosekov, Konstantin; Köster, Ulli; Türler, Andreas; Fischer, Eliane; Schibli, Roger (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European journal of nuclear medicine and molecular imaging, 41(10), pp. 1907-1915. Springer 10.1007/s00259-014-2798-3 <http://dx.doi.org/10.1007/s00259-014-2798-3> doi:10.7892/boris.63927 info:doi:10.1007/s00259-014-2798-3 urn:issn:1619-7070 |
| Idioma(s) |
eng |
| Publicador |
Springer |
| Relação |
http://boris.unibe.ch/63927/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Grünberg, Jürgen; Lindenblatt, Dennis; Dorrer, Holger; Cohrs, Susan; Zhernosekov, Konstantin; Köster, Ulli; Türler, Andreas; Fischer, Eliane; Schibli, Roger (2014). Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model. European journal of nuclear medicine and molecular imaging, 41(10), pp. 1907-1915. Springer 10.1007/s00259-014-2798-3 <http://dx.doi.org/10.1007/s00259-014-2798-3> |
| Palavras-Chave | #570 Life sciences; biology #540 Chemistry |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
